Share this on:
 E-mail
6
VIEWS
0
COMMENTS
 
SHARES
About this iReport
  • Not vetted for CNN

  • Click to view junegirl1's profile
    Posted June 20, 2014 by
    junegirl1

    More from junegirl1

    Advancing innovative treatments

     
    Kala Pharmaceuticals, Inc. is advancing innovative treatments for ocular diseases addressing significant needs in both front and back of the eye based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology. Kala's topical ocular MPP formulations enhance penetration into ocular tissue by facilitating penetration through the mucus layer of tear film.

    Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering.

    For more information, please visit www.kalarx.com.
    • TAGS:

    What do you think of this story?

    Select one of the options below. Your feedback will help tell CNN producers what to do with this iReport. If you'd like, you can explain your choice in the comments below.
    Be and editor! Choose an option below:
      Awesome! Put this on TV! Almost! Needs work. This submission violates iReport's community guidelines.

    Comments

    Log in to comment

    iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.

    Add your Story Add your Story